SCHEMBL15964334

SCHEMBL15964334

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccc5occc5c4)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ATM Q13315 1/20 0.46
DYRK1A Q13627 4/20 0.38
CA2 P00918 2/20 0.38
CA12 O43570 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
CDK9 P50750 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
PTGER4 P35408 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
PGR P06401 1/20 0.35
KMT2A Q03164 2/20 0.35
IL1R1 P14778 1/20 0.35
TSPO P30536 1/20 0.34
HDAC4 P56524 1/20 0.34
MAT2A P31153 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15965710 0.90 GPR84 (0.40) L3MBTL1KDM4EATMDYRK1ACA2
SCHEMBL20426789 0.84 L3MBTL1 (0.49) L3MBTL1KDM4EATMEDNRBEDNRA
SCHEMBL20426607 0.84 L3MBTL1 (0.49) L3MBTL1KDM4EATMEDNRBEDNRA
SCHEMBL16171579 0.83 L3MBTL1 (0.58) L3MBTL1KDM4EATMPTGER4EDNRB
SCHEMBL20426791 0.83 L3MBTL1 (0.46) L3MBTL1KDM4EATMDYRK1ACA2
SCHEMBL20426598 0.83 L3MBTL1 (0.46) L3MBTL1KDM4EATMDYRK1ACA2
SCHEMBL24004448 0.82 L3MBTL1 (0.53) L3MBTL1KDM4EATMPTGER4EDNRB
SCHEMBL17342664 0.82 L3MBTL1 (0.53) L3MBTL1KDM4EATMPTGER4EDNRB
SCHEMBL19500766 0.82 L3MBTL1 (0.53) L3MBTL1KDM4EATMPTGER4EDNRB
SCHEMBL16171581 0.82 L3MBTL1 (0.56) L3MBTL1KDM4EATMPTGER4EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49237-E1 Organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2022-10-04 US disclosed
US-10707434-B2 Organic electroluminescence element, and material for organic electroluminescence element IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed
US-20190019972-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2019-01-17 US disclosed
US-9397307-B2 Organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2016-07-19 US disclosed
US-9397307-B2 Organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2016-07-19 US disclosed
US-20140306207-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-10-16 US disclosed
US-20140231769-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-08-21 US disclosed
US-20140231769-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019972-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT LEF1, L1CAM, AGO2 L3MBTL1 1678/4885KDM4E 3248/4885ATM 2324/4885
US-10707434-B2 Organic electroluminescence element, and material for organic electroluminescence element LEF1, L1CAM, AGO2 L3MBTL1 1678/4885KDM4E 3248/4885ATM 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.